Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice (Q34957338)

5 August 2017

Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice (English)

1 reference

5 August 2017

1 reference

Samuele De Minicis

1

1 reference

5 August 2017

Chiara Rychlicki

2

1 reference

5 August 2017

Laura Agostinelli

3

1 reference

5 August 2017

Stefania Saccomanno

4

1 reference

5 August 2017

Cinzia Candelaresi

5

1 reference

5 August 2017

Luciano Trozzi

6

1 reference

5 August 2017

Eleonora Mingarelli

7

1 reference

5 August 2017

Bruna Facinelli

8

1 reference

5 August 2017

Gloria Magi

9

1 reference

5 August 2017

Claudio Palmieri

10

1 reference

5 August 2017

Marco Marzioni

11

1 reference

5 August 2017

Antonio Benedetti

12

1 reference

5 August 2017

Gianluca Svegliati-Baroni

13

1 reference

5 August 2017

language of work or name

English

0 references

publication date

25 February 2014

1 reference

5 August 2017

1 reference

5 August 2017

59

1 reference

5 August 2017

5

1 reference

5 August 2017

1738-1749

1 reference

Nonalcoholic fatty liver disease

5 August 2017

1 reference

7 January 2021

Non-alcoholic steatohepatitis-induced fibrosis: Toll-like receptors, reactive oxygen species and Jun N-terminal kinase

1 reference

7 January 2021

Hepatocellular carcinoma

1 reference

7 January 2021

Nonalcoholic fatty liver disease: a feature of the metabolic syndrome

1 reference

7 January 2021

Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications

1 reference

7 January 2021

A core gut microbiome in obese and lean twins

1 reference

7 January 2021

Microbial ecology: human gut microbes associated with obesity

1 reference

7 January 2021

The gut microbiota as an environmental factor that regulates fat storage

1 reference

7 January 2021

Gut microbiome, obesity, and metabolic dysfunction

1 reference

7 January 2021

Bacterial translocation and changes in the intestinal microbiome in mouse models of liver disease

1 reference

7 January 2021

Bacterial translocation of enteric organisms in patients with cirrhosis

1 reference

7 January 2021

Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity

1 reference

7 January 2021

Inflammasomes in liver diseases

1 reference

7 January 2021

Gene expression profiles during hepatic stellate cell activation in culture and in vivo

1 reference

7 January 2021

Intestinal epithelial cells as producers but not targets of chronic TNF suffice to cause murine Crohn-like pathology

1 reference

7 January 2021

PDX-1/Hes-1 interactions determine cholangiocyte proliferative response to injury in rodents: possible implications for sclerosing cholangitis

1 reference

7 January 2021

Reduced nicotinamide adenine dinucleotide phosphate oxidase mediates fibrotic and inflammatory effects of leptin on hepatic stellate cells

1 reference

7 January 2021

Insulin resistance and necroinflammation drives ductular reaction and epithelial-mesenchymal transition in chronic hepatitis C.

1 reference

7 January 2021

Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms

1 reference

7 January 2021

From the metabolic syndrome to NAFLD or vice versa?

1 reference

7 January 2021

The core gut microbiome, energy balance and obesity

1 reference

7 January 2021

High-fat diet determines the composition of the murine gut microbiome independently of obesity

1 reference

7 January 2021

Obesity, metabolic syndrome, and microbiota: multiple interactions

1 reference

7 January 2021

Toll-like receptor 2-mediated intestinal injury and enteric tumor necrosis factor receptor I contribute to liver fibrosis in mice

1 reference

7 January 2021

Endotoxin- and D-galactosamine-induced liver injury improved by the administration of Lactobacillus, Bifidobacterium and blueberry.

1 reference

7 January 2021

Protective role of supplement with foreign Bifidobacterium and Lactobacillus in experimental hepatic ischemia-reperfusion injury

1 reference

7 January 2021

Endotoxin from various gram-negative bacteria has differential effects on function of hepatic cytochrome P450 and drug transporters

1 reference

7 January 2021

TLR4 enhances TGF-beta signaling and hepatic fibrosis

1 reference

7 January 2021

Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases.

1 reference

7 January 2021

Selective Activation of Nuclear Bile Acid Receptor FXR in the Intestine Protects Mice Against Cholestasis

1 reference

7 January 2021

Effects of bile duct ligation and cholic acid treatment on fatty liver in two rat models of non-alcoholic fatty liver disease

1 reference

7 January 2021

Bile acids as regulators of hepatic lipid and glucose metabolism

1 reference

7 January 2021

Innate immunity: Caspase 8 prevents inflammasome activation

1 reference

7 January 2021

Innate immunity and alcoholic liver disease.

1 reference

7 January 2021

IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice

1 reference

7 January 2021

Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH.

1 reference

7 January 2021

Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease.

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.26695

1 reference

5 August 2017

1 reference